Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L01 ANTINEOPLASTIC AGENTS
      L01X OTHER ANTINEOPLASTIC AGENTS
        L01XC Monoclonal antibodies
          L01XC17 Nivolumab
            D10316  Nivolumab (USAN/INN) <JP/US>

USP drug classification [BR:br08302]
  Antineoplastics
    Monoclonal Antibody/Antibody-Drug Conjugate
      Nivolumab
        D10316  Nivolumab (USAN/INN)

Therapeutic category of drugs in Japan [BR:br08301]
  4  Agents affecting cellular function
    42  Antineoplastics
      429  Miscellaneous
        4291  Other Antitumors
          D10316  Nivolumab (USAN/INN); Nivolumab (genetical recombination) (JAN)	L01XC17

Target-based classification of drugs [BR:br08310]
  Cell surface molecules and ligands
    Other cell surface molecules
      Immune checkpoints
        PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]
          D10316  Nivolumab (USAN/INN) <JP/US>	Monoclonal antibody

[ BRITE | KEGG2 | KEGG ]